Document Detail


Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
MedLine Citation:
PMID:  8457237     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Topical glucocorticosteroids are useful in the treatment of various skin diseases. Although there are already many corticosteroids available, there is still need for highly potent and well tolerated ones. The anti-inflammatory activity of methylprednisolone aceponate (MPA, CAS 86401-95-8) has been investigated in 165 healthy volunteers of either sex. UV-B irradiation or cellophane tape stripping has served to produce erythema. First, the dose response relationship of MPA ointment (0.01%, 0.05%, 0.1% and 0.5%) has been evaluated. MPA effects have been related to those of the vehicle and difluocortolone 21-valerate 0.1% (DFV) ointment. Then the activity of 0.1% MPA (cream, ointment and fatty ointment) has been related to those of the respective vehicles as well as commercially available preparations of five corticosteroids: betamethasone 17,21-dipropionate 0.64% (BDP), betamethasone 17-valerate 0.1% (BV), clobetasol 17-propionate 0.05% (CP), hydrocortisone 17-butyrate 0.1% (HCB), prednicarbate 0.25% (P). In each experiment, MPA activity significantly exceeded that of the respective vehicle (p < or = 0.05). MPA 0.01-0.5% ointment exhibited strong anti-inflammatory activity, at least corresponding to that of 0.1% DFV ointment. A dose-dependent activity could only be observed in the UV-B-erythema test using 3 fold MED (minimal erythema doses) for irradiation, a test model differentiating strong corticosteroids. The comparison of 0.1% MPA formulations with respective reference preparations showed the following results: On stripped skin no significant differences could be detected which is demonstrated in the example of cream formulations.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
A Kecskés; P Jahn; H Wendt; R Kleine-Kuhlmann; L Lange
Related Documents :
24867497 - Acute toxic effects of single dose dacarbazine: hematological and histological changes ...
23002117 - A phase i trial of the anti-inhibitory kir monoclonal antibody iph2101 for acute myeloi...
15689177 - Adaptation of the human skin by chronic solar-simulating uv irradiation prevents ultrav...
16271747 - Mercury distribution in the skin of beluga (delphinapterus leucas) and narwhal (monodon...
16554457 - Effect of low-dose baclofen administration on plasma insulin-like growth factor-i in pe...
1487557 - Can fluoroquinolones be considered once-daily therapy?
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Arzneimittel-Forschung     Volume:  43     ISSN:  0004-4172     ISO Abbreviation:  Arzneimittelforschung     Publication Date:  1993 Feb 
Date Detail:
Created Date:  1993-04-22     Completed Date:  1993-04-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372660     Medline TA:  Arzneimittelforschung     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  144-7     Citation Subset:  IM    
Affiliation:
Department of Human Pharmacology, Schering Aktiengesellschaft, Berlin.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adult
Anti-Inflammatory Agents / pharmacology*
Dose-Response Relationship, Drug
Double-Blind Method
Erythema / drug therapy
Female
Glucocorticoids
Humans
Male
Methylprednisolone / analogs & derivatives*,  pharmacology
Middle Aged
Skin / drug effects*
Ultraviolet Rays
Vasoconstrictor Agents / pharmacology
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Glucocorticoids; 0/Vasoconstrictor Agents; 83-43-2/Methylprednisolone; 86401-95-8/methylprednisolone aceponate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
Next Document:  Pharmacokinetic study of 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate in the rat.